GET DAILY SIGNALSAxon Enterprise (AXON): A Closer Look at Its Transition to a Public-Safety Platform
Key Takeaways
- AXON represents Axon Enterprise, Inc., a public-safety technology firm recognized for its TASER conducted energy weapons and the Axon body-camera and cloud-software system.
- Established in 1993 as TASER International, the company is based in Scottsdale, Arizona, and adopted the Axon Enterprise name in 2017.
- Operations span two segments—Software and Services, and Connected Devices—pairing hardware sales with recurring, multi-year software subscriptions.
- Axon serves law enforcement, federal and international agencies, corrections, and commercial clients, while expanding into artificial intelligence, drones, and counter-drone solutions.
Introduction
Axon Enterprise, Inc. (AXON) develops connected hardware and cloud software tailored for public safety and security needs. The company is widely known for the TASER line of conducted energy weapons and the Axon body cameras adopted by many law enforcement agencies. I follow the stock because of its shift from a hardware-focused business to a software-driven platform that ties devices to a recurring-revenue cloud ecosystem covering digital evidence management, records, real-time operations, and artificial intelligence.
Company Background
Axon traces its roots to 1993 when it launched as TASER International, Inc., before rebranding to Axon Enterprise, Inc. in April 2017. Incorporated in Arizona and headquartered in Scottsdale, the firm is led by founder and Chief Executive Officer Patrick W. "Rick" Smith and employs approximately 5,000 people. Shares trade on the Nasdaq Global Select Market under the ticker AXON.
The business centers on an integrated “public-safety operating system” that links hardware with software. Results break down into two segments. The Software and Services segment delivers cloud-based SaaS solutions such as Axon Evidence, Axon Records, Axon Fusus, Axon Assistant, and Draft One, an AI-powered report-writing tool. The Connected Devices segment focuses on hardware including TASER energy weapons, Axon body cameras, in-car and fixed cameras, drone and counter-drone technologies, and virtual-reality training equipment.
Revenue stems mainly from device and cartridge sales plus recurring subscriptions for software, cloud storage, and extended warranties. Sales reach customers through direct teams, distribution partners, and resellers, serving law enforcement, federal and international government entities, corrections, commercial enterprises, and consumers. A hallmark is the “land-and-expand” approach where initial hardware purchases lead to added software subscriptions, supporting a high level of recurring revenue. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Position
Axon maintains a leading position in conducted energy weapons and law-enforcement body cameras in the United States, with agencies served in more than 100 countries. Its edge comes from the integration of hardware with a cloud network that increases product utility and supports customer retention. The company has extended its reach beyond policing into federal defense and security, corrections, enterprise security, and international markets, while investing in areas such as artificial intelligence, robotics, and drone-as-first-responder programs.
What Attracts Investors to AXON
Investors track AXON due to its move toward high-margin, recurring software revenue and its long expansion runway. Multi-year subscription contracts and high net revenue retention create durable, predictable income, while the installed base of body cameras and TASER devices offers a base for software upselling. Growth into AI-driven productivity tools, real-time operations, and counter-drone systems opens additional avenues beyond core hardware. A diversified and expanding customer base that includes international governments and commercial enterprises further reduces reliance on any single market.
Risks and Key Considerations
Several factors warrant attention. Axon competes in less-lethal weapons, body cameras, and evidence-management software, where technological shifts could affect its standing. A notable share of revenue comes from government and public-sector customers, whose budgets and procurement can vary with policy changes, elections, and economic conditions. Expansion into AI and defense-adjacent products may involve regulatory, ethical, and public-scrutiny issues. Heavy investment in new categories can pressure margins, and reliance on multi-year contracts means revenue recognition and growth may vary between periods. As with many growth-oriented technology companies, valuation may embed high expectations for future results.
Using Tickeron’s AI Screener
In my own research process, I frequently turn to Tickeron’s AI Screener to filter stocks and ETFs by technical indicators, fundamentals, volatility, trends, AI-generated signals, industries, price patterns, and custom criteria. The platform helps surface ideas that align with specific strategies and saves time versus manual screening. I have found it useful for building watchlists and refining approaches with data-driven insights.
Conclusion
Axon Enterprise has developed from a conducted energy weapons manufacturer into an integrated public-safety technology platform that connects hardware, cloud software, and artificial intelligence. Its recurring-revenue software model, established relationships with law enforcement, and expansion into new security areas set it apart in the aerospace-and-defense and technology space. Those qualities make AXON a noteworthy name for investors examining how software and connected devices are reshaping public safety and enterprise security.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AXON's RSI Indicator slumps oversold zone
The RSI Indicator for AXON moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 55 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 32 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a clinical-stage biopharmaceutical company
Industry AerospaceDefense
Advertisement